Gene expression analysis fails to identify patients with chronic myeloid leukemia who will achieve cytogenetic response to imatinib

Haematologica. 2005 Apr;90(4):434.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Chromosomes / drug effects
  • Cytogenetic Analysis / methods
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate